Pharmaceuticals

Overview

Twenty-four of the top 30 pharmaceutical firms and a broad range of companies across life sciences and health care choose Cognos performance management software.

These companies use Cognos to:

Manage performance in product development

• Analyze and report on clinical performance data to identify best practices.
• Analyze performance data to improve resource allocation.
• Monitor key performance indicators to identify problems quickly.
• Consolidate data from multiple sources to identify trends, anomalies, or opportunities.
• Forecast predictable and consistent future results.
• Leverage investments in ERP and other data

Improve operational performance

• Analyze and report on your operational data for more accurate and timely business decisions.
• Get real-time visibility into the organization.
• Use driver-based planning models to deliver timely, accurate forecasts and optimized resource utilization.
• Improve manufacturing process and inventory control.
• Provide information to help guide your executive management team.

Improve sales and marketing performance

• Consolidate customer, channel, and product data for a single view of revenue and market share.
• Analyze and report on product sales and sales force activity.
• Analyze the effectiveness and ROI of your various marketing techniques.
• Deliver timely, accurate forecasts with driver-based modeling.
• Monitor national, regional, territory, and product performance using dashboards and scorecards.

Comply with regulatory requirements

• Structure your data and reporting to comply with HIPAA, CFR 21, PDMA, and FDA NDA processes.

Benefits and Value

Cognos integrated performance management software and services deliver value to the world’s leading pharmaceutical and life sciences companies.

Reporting, analysis, and business intelligence
Cognos offers the most comprehensive reporting coverage in the industry. Build financial statements, CRO performance reports, territory sales reports, and more.

You can use BI software to:

• Decide whether to continue, pursue, or terminate a project (compound, device, molecule).
• Evaluate companies that might be appropriate partners or M&A candidates.
• Identify different or "off-label" uses for existing products.
• Locate researchers who may become important opinion leaders for your company or your competitors.
• Publish reports from a centralized product research & development group and allow self-service ad hoc reporting for global users.
• Share information with key partners and contract manufacturers through a BI extranet.

Learn more about Cognos reporting, analysis, and business intelligence software.

Planning, forecasting, and consolidation
Pharmaceutical companies that choose Cognos planning and consolidation software have the highest market capitalization in the industry.

You can use planning and consolidation software to:

• Augment or replace cumbersome spreadsheet-based systems.
• Enable driver-based planning to streamline and focus efforts around HR plans, manufacturing requirements, or Sales resources.
• Use rolling forecasts to increase forward visibility into financial performance.
• Reduce consolidation, close, and reporting cycles by days or weeks.
• Manage multiple reporting and consolidation standards such as IAS and U.S.-based GAAP; intercompany elimination and reconciliation; multicurrency translation; complex ownership calculations and financial consolidation rules.
• Conduct what-if scenarios for different revenue projections or changes in business lines.

Learn more about Cognos planning and consolidation software.

Scorecarding
Enable drug portfolio management from your desktop.

With Cognos scorecarding software, you can:

• Monitor performance against key milestones such as investigator selection, IRBs, site initiations, enrollment, drug shipments, and availability.
• Create key performance indicators for performance of a specific country, compound, sales rep, therapy area, or entire study.
• Monitor your clinical trials performance with regards to speed, timeliness, data quality, and staff and investigator performance.
• Interconnect these performance indicators and model your entire drug development plans and strategies.

Learn more about Cognos scorecarding software.

Cognos Clincal Trial Forecasting and Sample Optimization Blueprints

Pharmaceutical companies are constantly looking to improve clinical trials management and optimize sample distribution across the sales force to better meet corporate revenue targets. Cognos Clinical Trial Forecasting and Cognos Sample Optimization Blueprints address these challenges. Based on proven best-practices in pharmaceutical operations planning, budgeting, and forecasting, these Blueprints equip customers with all of the necessary technology and process design choices, enabling them to synchronize and coordinate financial and operational plans in order to make better resource allocation decisions.

Clinical trials represent one of the biggest direct-spend components in most pharmaceutical R&D budgets. The new Cognos Clinical Trial Forecasting Blueprint helps pharmaceutical companies better anticipate clinical trial resource requirements and accompanying expenses in order to comply with FDA filing requirements. Capitalizing on the robust multi-dimensional modeling and integrated workflow capabilities of Cognos 8 BI and the new Performance Blueprint, organizations can more accurately forecast, plan and manage trial expenses; recognize and correct under-performing clinical trials; consolidate all trials to facilitate enterprise-wide visibility and analysis; and drive greater accountability and control at each stage of the trial.